(August 17, 2023, 6:59 PM EDT) -- WASHINGTON, D.C. — Arguing that the Federal Circuit U.S. Court of Appeals correctly found that three organ rejection detection patents pertain to natural phenomena that are unprotectable under Section 101 of the Patent Act, a DNA testing firm and a drug development solutions company filed briefs opposing a petition for certiorari seeking clarification of the statute’s scope....